Home / Recalls / Strides Pharma Inc. / D-0260-2024

D-0260-2024 Class II Terminated

Recalled by Strides Pharma Inc. — East Brunswick, NJ

Recall Details

Product Type
Drugs
Report Date
January 31, 2024
Initiation Date
December 29, 2023
Termination Date
July 1, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
396 50-count bottles

Product Description

Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India. Distributed by:Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-752-16

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

Nationwide in the USA

Code Information

Lot #: 7253092B, Exp Date 09/30/2025

Other recalls by Strides Pharma Inc.

  • D-0546-2025 Class II — Cinacalcet Tablets 90 mg, 30-count bottles, Rx only, Manufactured by: Strides Ph (July 9, 2025)
  • D-0294-2025 Class II — Testosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distrib (March 5, 2025)
  • D-0293-2025 Class II — Testosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton, Rx only, Dist (March 5, 2025)
  • D-0895-2023 Class II — Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx (June 26, 2023)
  • D-1330-2022 Class II — Prednisone Tablets USP, 20 mg, 100-count bottle, Rx Only, Manufactured by: Strid (July 19, 2022)
  • D-0973-2022 Class II — Losartan Potassium Tablets, USP, 50 mg, Rx Only, Manufactured by: Vivimed Life S (May 18, 2022)
  • D-0974-2022 Class II — Losartan Potassium Tablets, USP, 100 mg, Rx Only, Manufactured by: Vivimed Life (May 18, 2022)
  • D-0972-2022 Class II — Losartan Potassium Tablets, USP 25 mg, Rx only, Manufactured by: Vivimed Life S (May 18, 2022)
  • D-0006-2022 Class II — Potassium Chloride Extended-Release Tablets, USP 10 mEq (750 mg), 500 Tablets, R (September 27, 2021)
  • D-0180-2021 Class III — NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured (December 22, 2020)